Updated Jul 16, 2026
Smethurst Dominic is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $77K.

Dominic Smethurst is identified as Chief Medical Officer of Corbus Pharmaceuticals Holdings, Inc. in the SEC filing dated January 16, 2026 (CIK 0001820549). The insider filing shows no purchases or sales by Mr. Smethurst and lists him among Corbus insiders. Corbus describes itself as a precision oncology company with a pipeline including CRB-701 and CRB-601.
| Role | Insider |
|---|---|
| Notability | 28/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-04 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | S — Open-market sale | 6.1K | $8.30 | $51K |
| 2026-02-04 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | S — Open-market sale | 3.3K | $8.09 | $27K |
| 2026-01-16 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | A — Grant or award | 28.4K | $0.00 |
Dominic Smethurst is identified as Chief Medical Officer of Corbus Pharmaceuticals Holdings, Inc. in the SEC filing dated January 16, 2026 (CIK 0001820549). The insider filing shows no purchases or sales by Mr. Smethurst and lists him among Corbus insiders. Corbus describes itself as a precision oncology company with a pipeline including CRB-701 and CRB-601.…
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($77K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Smethurst Dominic profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.